**Correction to:** *Oncogene* (2016) **35,** 5000--5009; doi:[10.1038/onc.2016.35](/doifinder/10.1038/onc.2016.35); published online 29 February 2016

Since the online publication of this article the authors found that one of the siRNAs used in [Figure 2f](#fig2){ref-type="fig"} was not specific for TTF-1/Nkx2.1. The authors thus wish to replace the figure with the new figure using siRNAs specific for TTF-1/Nkx2.1. The authors apologize for any inconvenience caused, and confirm that the conclusions drawn from this research are not affected by this correction.

![(**f**) H441 cells were transfected with human RBM47 promoter-reporter construct in combination with control or TTF-1 siRNAs (siTTF-1\#1 (HSS144278), siTTF-1\#3 (HSS144277) and siTTF-1\#4 (HSS144279; Thermo Fisher Scientific)). At 48 h after transfection, cells were collected and assayed for luciferase activities. siCT: control siRNA. Averages and standard deviations of the two independent experiments were shown for each condition. The Tukey−Kramer test of the R program (<http://www.r-project.org/>) was used for multiple comparisons of the data. F-test was performed for the equality of variances.](onc2017191f2){#fig2}
